152 filings
Page 5 of 8
CORRESP
m9twerd8
3 Nov 21
Correspondence with SEC
12:00am
POS AM
v5gi 1sfsrv7
29 Oct 21
Prospectus update (post-effective amendment)
4:17pm
8-K
fntawx 8l35p9mh6wzpv
29 Oct 21
MedMen Announces Promotion of Roz Lipsey to Chief Operating Officer
4:15pm
UPLOAD
s4jfz61cryo53hnuf5
26 Oct 21
Letter from SEC
12:00am
8-K
ypwsk867v3d6mrh67
19 Oct 21
Departure of Directors or Certain Officers
4:02pm
8-K
rrbi4puc
24 Sep 21
Departure of Directors or Certain Officers
4:12pm
10-K
bvv 3ezih
24 Sep 21
Annual report
4:10pm
8-K
48vik6
23 Sep 21
Company Continues to Execute Against MedMen 2.0 Growth Plan, Fueled by Recent Capital Infusion and Partnerships with Tilray and Serruya Private Equity
4:52pm
424B3
2kfb9xg9w68
23 Aug 21
Prospectus supplement
6:03am
424B3
jerg9bi
23 Aug 21
Prospectus supplement
6:03am
8-K
k3pbzvcz
20 Aug 21
Entry into a Material Definitive Agreement
5:17pm
424B3
x6hqa9yve8y
20 Jul 21
Prospectus supplement
2:16pm
424B3
o71lnrz m89ybyl6
20 Jul 21
Prospectus supplement
6:12am
EFFECT
tdgl8f0
19 Jul 21
Notice of effectiveness
12:15am
8-K
gch5ek2h2q mqx8
15 Jul 21
MedMen Announces Permanent Appointment of Tom Lynch as Chief Executive Officer
5:13pm
CORRESP
sn95kgvobe8mq
15 Jul 21
Correspondence with SEC
12:00am